Autism Information

Tuesday, July 25, 2006

L-Carnosine for Autism treatment

L- Carnosine
Carnitine was first isolated in 1900 and is present in both human and animal tissue. Some of its characteristics include protection of various body tissues from free radicals including free radical damage to essential fatty acids found in cell membranes. Research has suggested that he could act as a protected against aldehyde formation created by sugars, yeast and proteins in which case it could be valuable in reducing the effects of acetylaldehydes created as a result of Candida yeast overgrowth.

One 8 week double blind carnosine study which included 31 autistic children conducted at the Autism and Epilepsy Specialty Services in Lake Bluff, Illinois reported that this nutrient may have antioxidant potential and could also act as a neurotransmitter. Using a dosage of 800 mg per day, the control group showed substantial improvement in behavior, vocabulary and picture recognition. 8
It has been theorized that L-carnosine modulates new transmission and affects all ion transfer of zinc and copper in the entorhinal cortex located at the front of the brain. The temporal and frontal lobes of the brain are responsible for control of emotion, instigation of epileptic activity, cognition, abstract thinking and expressive speech.

One anecdotal story from Chicago reported that an 8year old boy and a six year-old girl both had significant changes in behavior and other improvements with the use of L-carnosine.
The lead researcher of this carnitine study Dr. M. Chez reported that of the 1000 autisic children that he has used Carnosine with, he has seen a 90% success rate and improvement with improvements seen within one week to eight weeks of administration.


Post a Comment

<< Home